ArticleCureus2026
Eosinophilic Fasciitis in Children: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Eosinophilic fasciitis (EF), also known as Shulman's disease, is a rare inflammatory and fibrosing disorder characterized by inflammation and eosinophilic infiltration of the fascia, leading to skin thickening and induration. It typically presents with limb edema progressing to induration and sclerosis and is frequently, but not invariably, associated with peripheral blood eosinophilia. Diagnosis relies on a combination of clinical, laboratory, imaging, and histopathological findings. We report the case of a 16-year-old female patient with a documented history of hypereosinophilic syndrome, moderate persistent asthma, and recurrent cutaneous abscesses, who presented with localized swelling of the left leg approximately one week after minor trauma. Clinical examination revealed a 3-cm fluctuant swelling with local inflammatory signs. Laboratory investigations showed a negative C-reactive protein level and an eosinophil count of 150/mm³, within the laboratory reference range. Soft-tissue ultrasonography demonstrated a subcutaneous collection measuring 24 × 17 mm. The patient received ceftriaxone for seven days without clinical improvement. Direct examination of purulent material showed no microorganisms, and culture was sterile. A deep skin and subcutaneous tissue biopsy revealed moderate fibrosis associated with a dense inflammatory infiltrate rich in eosinophils, with no evidence of malignancy. Based on the clinical and histopathological findings, EF was considered the most likely diagnosis. Systemic corticosteroid therapy was initiated at 1 mg/kg/day, resulting in progressive clinical improvement. This case highlights the diagnostic challenge of localized EF in the absence of peripheral blood eosinophilia and in a patient with a history of recurrent abscesses and hypereosinophilic syndrome. EF should therefore be considered in the differential diagnosis of persistent indurated limb swelling, even when the presentation is localized and mimics an infectious process.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.